研究目的
Designing an upconversion luminance fueled DNA-Azo nanopump for rapid and efficient drug release in cancer therapy.
研究成果
The DNA-Azo nanopump demonstrates efficient and controllable drug release under NIR irradiation, leading to enhanced anticancer therapy. The system shows good biocompatibility and potential for clinical applications in chemotherapy.
研究不足
The study focuses on the design and preliminary evaluation of the DNA-Azo nanopump. Further optimization and comprehensive in vivo studies are needed to fully assess its therapeutic potential and safety.
1:Experimental Design and Method Selection:
The nanopump was constructed by assembling Azo-functionalized DNA strands on upconversion nanoparticles (UCNPs). DOX was loaded through its intercalation with DNA helix.
2:Sample Selection and Data Sources:
HepG2 cells were used to evaluate the therapeutic efficiency.
3:List of Experimental Equipment and Materials:
NaYF4:Tm,Yb core UCNPs, poly(acrylic acid) modified UCNPs, Azo-functionalized DNA strands, DOX.
4:Experimental Procedures and Operational Workflow:
The nanopump was exposed to NIR irradiation to trigger DOX release. Cellular and in vivo therapeutic efficiencies were evaluated.
5:Data Analysis Methods:
Fluorescence intensities of DOX in supernatants were measured to evaluate release efficiency. Cell proliferation and apoptosis rates were assessed using MTT assay and flow cytometric assay, respectively.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容